Status:
COMPLETED
Prospective Ultrafast MRI Radiomics for Breast Cancer
Lead Sponsor:
Korea University Ansan Hospital
Conditions:
Breast Cancer
Eligibility:
FEMALE
27-86 years
Brief Summary
The goal of this prospective study is to investigate the performance of ultrafast MRI radiomics in classifying histological factors and subtypes of breast cancer compared with standard MRI among radio...
Eligibility Criteria
Inclusion
- Diagnosed with invasive breast cancer
Exclusion
- Diagnosed with other cancer
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT06104189
Start Date
October 1 2021
End Date
August 31 2023
Last Update
October 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bo Kyoung Seo
Ansan, South Korea, 15355